News | Women's Health | May 11, 2017

3-D Mammography Changing the Face of Cancer Screening and Treatment

Global market research gives insight to the competitive mammography landscape

mammography exam

Photo courtesy of Hologic

Breast cancer is one of the leading causes of death of women worldwide. In Canada, according to the Canadian Cancer Society, one in every nine women is expected to develop breast cancer in her lifetime, and one in thirty will die from it. Though breast cancer rates were high relatively high in the 1990s, they decreased in the 2000s—and continue to remain much lower than they were in the 80s and 90s—thanks to the increased use of mammography. Mammography can detect early breast cancer in women experiencing no symptoms and is an essential tool and lifesaving measure. According to Infiniti Research, the global market for mammography devices and equipment will grow at a rate of more than 9 percent until 2020.

Infiniti Research has recently completed a market assessment on the mammography device market for a leading global manufacturer and supplier of diagnostic products, medical imaging systems, and surgical products. The purpose of this study was to help the client assess and analyze the competitive landscape for mammography devices.

 

Market Trends

Though 2-D mammography has long been an effective and affordable industry standard, 3-D mammography is becoming more popular. While 2-D mammography captures two static images of the breast, 3-D mammography takes multiple images of the breast, allowing for a more comprehensive and accurate picture, and reducing the risk of missing abnormalities due to image overlap. However, the benefits of 3-D mammography over 2-D have yet to be fully proven, and 3-D mammography is more expensive for uninsured patients. Another popular method involves combining 2-D and 3-D mammography, though this is currently very new. Some studies have suggested that 3-D mammography puts the patient at a higher risk for cancer from radiation, though this has not yet been confirmed.

 

Market Opportunities

Because the use of 3-D and combination 2-D and 3-D mammography is still relatively new and the risks associated with it are still largely unknown or unconfirmed, market intelligence is critical for vendors looking to enter this market. To keep their patients safe and establish themselves as reliable, vendors need to be up-to-date on market trends and developments, medical advancements and challenges, and how breast cancer incidence and treatment differs around the world.

In their latest assessment of the global mammography device market, Infiniti’s market intelligence analysts helped their client, a leading global manufacturer and supplier of diagnostic products, to gain an in-depth understanding of how the competitive landscape for mammography devices and equipment differed across the world, with special focus on target countries including the US, Germany, China, Great Britain, Australia, and France. Infiniti’s analysts researched and monitored the latest developments in the market through journals and whitepapers, and also conducted extensive interviews with stakeholders such as channel partners, business executives, and suppliers in order to develop a holistic overview of the market scenario.

 

You can view the complete study here: https://www.infinitiresearch.com/casestudy/competitive-intelligence-assessment-mammography-devices

Related Content

Volpara Solutions to Showcase VolparaEnterprise Live! at RSNA
News | Mammography | October 16, 2017
Volpara Solutions will introduce VolparaEnterprise Live!, a mammography quality control tool, at the 2016 Radiological...
TMIST Mammography Study Opens Enrollment
News | Mammography | October 16, 2017
The Tomosynthesis Mammographic Imaging Screening Trial (TMIST), the first randomized trial to compare two types of...
National Breast Center Founder Names Top Three Innovations in Breast Cancer Treatment
News | Women's Health | October 11, 2017
In 2017, invasive breast cancer will be diagnosed in about 252,710 women and 2,470 men in the U.S. and remains the...
News | Brachytherapy Systems | October 05, 2017
External researchers presented new clinical data supporting the use of iCAD’s Xoft Axxent Electronic Brachytherapy (eBx...
Joint Venture Partnership Opening 16 New Breast Screening Sites in Texas
News | Breast Imaging | October 04, 2017
HCA Healthcare Gulf Coast Division and Solis Mammography have entered into a joint venture agreement to make breast...
International Trial Confirms Safety, Effectiveness of High-Dose Brachytherapy Plus Pelvic Radiation for Cervical Cancer
News | Brachytherapy Systems, Women's Healthcare | October 04, 2017
Findings from a new multicenter, international clinical trial confirm the effectiveness of high-dose brachytherapy or...
Kubtec Announces Expansion of 3-D Tomosynthesis Technology
News | Digital Radiography (DR) | October 04, 2017
October 4, 2017 — Kubtec announced at the annual conference of the American Association of Pathology Assistants (AAPA
The Siemens Acuson

The Siemens Acuson

Feature | Breast Imaging | October 04, 2017 | By Melinda Taschetta-Millane
According to a new Market Study Report,1 the automated breast ultrasound system (ABUS) market will see a 21 percent...
Why guidelines aren't just for patients

Image courtesy of Eizo

Feature | Women's Health | October 04, 2017 | By Stamatia Destounis, M.D., FACR
Over the years, significant progress has been made educating women, men and families about breast cancer — the pink...
Hologic’s new Brevera breast biopsy system allows real-time tissue sample collection and verification on one system

Hologic’s new Brevera breast biopsy system allows real-time tissue sample collection and verification on one system.

Feature | Breast Imaging | October 03, 2017 | By Jeff Zagoudis
When it comes to breast imaging, mammography has long been the gold standard among breast cancer detection technologies...
Overlay Init